Search results
Showing results for
The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.
Emma Plested
Emma Plested - Programme and Regulatory Affairs Director (UK)
Parvinder Aley
OBE, PhD Parvinder Aley - Director of Global Operations (OVG)
Yama G.Farooq
BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director
Stephane Paulus
MD, DTM&H, FRCPCH Stephane Paulus - Consultant in Paediatric Infectious Diseases
Daniel O'Connor
BSc AFHEA MSc DPhil (OXON) Daniel O'Connor - Associate Professor | Head of Bioinformatics
Robert Shaw
MA (Cantab), MSci (Cantab), MBBS (Imp), MRCP (UK), DPhil (Oxon) Robert Shaw - Senior Vaccine Clinical Trials Physician

